These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3463504)

  • 1. [Vaccines against old and new microorganisms].
    Penttinen K
    Duodecim; 1986; 102(16):1100-3. PubMed ID: 3463504
    [No Abstract]   [Full Text] [Related]  

  • 2. [The vaccinia virus as a vector for genetically engineered vaccines and the study of viral protein functions].
    Vopr Virusol; 1986; 31(4):509-12. PubMed ID: 3464128
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of genetic engineering methods to create viral vaccines].
    Tatarov G
    Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657
    [No Abstract]   [Full Text] [Related]  

  • 4. New developments in the construction of safer and more versatile pseudorabies virus vaccines.
    Mettenleiter TC
    Dev Biol Stand; 1995; 84():83-7. PubMed ID: 7796971
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards antiviral oligopeptide vaccines.
    Niesters HG; van der Zeijst BA
    Microbiol Sci; 1984 Jun; 1(3):55-8. PubMed ID: 6086077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic gene technology for new vaccines].
    Mäkelä PH
    Duodecim; 1988; 104(22):1874-80. PubMed ID: 3065068
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prospects for the development of viral vaccines].
    Bektimirov TA; Gorbunov MA
    Voen Med Zh; 1995 Jul; (7):45-8. PubMed ID: 7571512
    [No Abstract]   [Full Text] [Related]  

  • 8. [New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. a. Application of genetic engineering using Saccharomyces cerevisiae].
    Sakamoto S
    Nihon Rinsho; 1987 Oct; 45(10):2322-5. PubMed ID: 3329247
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live virus vaccines: something old, something new, something borrowed..
    Dubensky TW; Polo JM; Liu MA
    Nat Med; 1998 Dec; 4(12):1357-8. PubMed ID: 9846565
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of live pseudorabies virus vaccines.
    Kimman TG; Gielkens AL; Glazenburg K; Jacobs L; de Jong MC; Mulder WA; Peeters BP
    Dev Biol Stand; 1995; 84():89-96. PubMed ID: 7796972
    [No Abstract]   [Full Text] [Related]  

  • 12. Are animal retroviruses potential candidates for an AIDS vaccine?
    Di Guardo G
    Acta Virol; 1990 Sep; 34(5):495. PubMed ID: 1981462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiviral vaccines].
    Girard M
    Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccines obtained by genetic engineering].
    Tron F
    Rev Prat; 1988 Jan; 38(1):45-9. PubMed ID: 3344394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategies for new vaccines against virus-induced diseases].
    Rosenthal S; Rosenthal HA
    Padiatr Grenzgeb; 1987; 26(2):89-93. PubMed ID: 3601411
    [No Abstract]   [Full Text] [Related]  

  • 17. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.
    Pérez-Filgueira DM; Resino-Talaván P; Cubillos C; Angulo I; Barderas MG; Barcena J; Escribano JM
    Virology; 2007 Aug; 364(2):422-30. PubMed ID: 17434554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR; Collins PL
    J Clin Invest; 2002 Jul; 110(1):21-7. PubMed ID: 12093883
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular basis for constructing artificial immunogens].
    Khaitov RM
    Mol Gen Mikrobiol Virusol; 1987 Nov; (11):3-8. PubMed ID: 3328044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.